^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    mavrilimumab (KPL-301)

    i
    Other names: KPL-301, CAM-3001, CAM 3001
    Associations
    News
    Trials
    Company:
    CSL Behring, Huadong Medicine, Kiniksa Pharmaceuticals
    Drug class:
    GM-CSFRα inhibitor
    Associations
    News
    Trials